Asterias Biotherapeutics Inc
(AST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,076 | 5,026 | 12,861 | 326 | 2,171 |
| Marketable Securities | 14,374 | 12,100 | 11,755 | 29,290 | 32,052 |
| Receivables | 496 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 7,572 | 7,974 | 12,245 | 15,568 |
| TOTAL | $18,384 | $25,050 | $32,873 | $42,251 | $50,132 |
| Non-Current Assets | |||||
| PPE Net | 1,045 | 1,252 | 1,390 | 1,426 | 1,461 |
| Investments And Advances | 416 | 416 | 416 | 416 | 416 |
| Intangibles | 23,502 | 26,115 | 26,841 | 27,566 | 28,292 |
| Other Non-Current Assets | 767 | 361 | 361 | 354 | 55 |
| TOTAL | $25,730 | $28,144 | $29,007 | $29,763 | $30,222 |
| Total Assets | $44,114 | $53,194 | $61,880 | $72,013 | $80,354 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 737 | 386 | 254 | 486 | 567 |
| Accrued Expenses | 430 | 140 | 275 | 217 | 96 |
| Other current liabilities | 615 | 7,979 | 13,407 | 15,392 | 17,633 |
| TOTAL | $6,497 | $8,505 | $13,936 | $16,094 | $18,296 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 378 | 0 | 0 | 0 | 0 |
| TOTAL | $4,986 | $10,787 | $14,244 | $6,929 | $8,278 |
| Total Liabilities | $11,483 | $19,292 | $28,180 | $23,023 | $26,573 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,312 | 30,902 | 30,899 | 30,499 | 30,499 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -33,236 | -29,909 | -28,227 | -25,425 | -23,139 |
| Other shareholders' equity | -503 | -3,044 | -3,389 | -5,697 | -2,935 |
| TOTAL | $32,631 | $33,902 | $33,699 | $48,990 | $53,781 |
| Total Liabilities And Equity | $44,114 | $53,194 | $61,880 | $72,013 | $80,354 |